Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Aflibercept by Regeneron Pharmaceuticals for Retinopathy: Likelihood of Approval
Aflibercept is under clinical development by Regeneron Pharmaceuticals and currently in Phase II for Retinopathy. According to GlobalData, Phase II...
Aflibercept by Regeneron Pharmaceuticals for Graves' Ophthalmopathy: Likelihood of Approval
Aflibercept is under clinical development by Regeneron Pharmaceuticals and currently in Phase II for Graves' Ophthalmopathy. According to GlobalData, Phase...
Aflibercept by Regeneron Pharmaceuticals for Optic Neuropathy: Likelihood of Approval
Aflibercept is under clinical development by Regeneron Pharmaceuticals and currently in Phase II for Optic Neuropathy. According to GlobalData, Phase...